| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Body-mass index and mortality among 1.46 million white adults.
|
N Engl J Med
|
2010
|
13.34
|
|
2
|
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
|
Nat Genet
|
2009
|
5.14
|
|
3
|
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
|
Nat Genet
|
2010
|
4.89
|
|
4
|
Detectable clonal mosaicism and its relationship to aging and cancer.
|
Nat Genet
|
2012
|
3.69
|
|
5
|
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
3.51
|
|
6
|
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer.
|
Am J Epidemiol
|
2006
|
3.41
|
|
7
|
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
|
JAMA
|
2013
|
3.40
|
|
8
|
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies.
|
JAMA
|
2005
|
2.76
|
|
9
|
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies.
|
J Natl Cancer Inst
|
2004
|
2.54
|
|
10
|
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
2.42
|
|
11
|
Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies.
|
Int J Epidemiol
|
2002
|
2.19
|
|
12
|
Genome-wide association study of glioma and meta-analysis.
|
Hum Genet
|
2012
|
1.96
|
|
13
|
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.95
|
|
14
|
Fruit and vegetable intake and risk of breast cancer by hormone receptor status.
|
J Natl Cancer Inst
|
2013
|
1.94
|
|
15
|
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
|
Arch Intern Med
|
2010
|
1.88
|
|
16
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
|
17
|
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
|
Cancer Res
|
2010
|
1.82
|
|
18
|
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.67
|
|
19
|
Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
|
Gut
|
2012
|
1.66
|
|
20
|
Reproducibility of serum cytokines and growth factors.
|
Cytokine
|
2008
|
1.61
|
|
21
|
Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies.
|
J Natl Cancer Inst
|
2007
|
1.57
|
|
22
|
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
|
Int J Cancer
|
2004
|
1.52
|
|
23
|
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.52
|
|
24
|
Circulating inflammation markers and risk of epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.44
|
|
25
|
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.40
|
|
26
|
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.
|
PLoS One
|
2013
|
1.33
|
|
27
|
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
|
Int J Cancer
|
2004
|
1.33
|
|
28
|
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.
|
J Natl Cancer Inst
|
2012
|
1.31
|
|
29
|
The potential protective effects of taurine on coronary heart disease.
|
Atherosclerosis
|
2009
|
1.27
|
|
30
|
Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.24
|
|
31
|
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
|
Int J Cancer
|
2002
|
1.24
|
|
32
|
Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer.
|
Cancer Causes Control
|
2010
|
1.22
|
|
33
|
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.
|
Carcinogenesis
|
2012
|
1.20
|
|
34
|
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.
|
Clin Cancer Res
|
2003
|
1.19
|
|
35
|
Promoter methylation and the detection of breast cancer.
|
Cancer Causes Control
|
2009
|
1.18
|
|
36
|
A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer.
|
Cancer Causes Control
|
2006
|
1.17
|
|
37
|
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
|
Cancer Causes Control
|
2012
|
1.17
|
|
38
|
Circulating levels of sex steroid hormones and risk of ovarian cancer.
|
Int J Cancer
|
2003
|
1.17
|
|
39
|
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.16
|
|
40
|
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.
|
Eur Cytokine Netw
|
2009
|
1.16
|
|
41
|
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
|
Cancer Causes Control
|
2010
|
1.14
|
|
42
|
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.11
|
|
43
|
Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.
|
Cancer Lett
|
2008
|
1.09
|
|
44
|
Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.
|
Int J Cancer
|
2008
|
1.08
|
|
45
|
Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
|
Int J Cancer
|
2010
|
1.07
|
|
46
|
Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).
|
Cancer Causes Control
|
2010
|
1.07
|
|
47
|
Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.04
|
|
48
|
Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.02
|
|
49
|
Determinants of maternal sex steroids during the first half of pregnancy.
|
Obstet Gynecol
|
2011
|
1.01
|
|
50
|
Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.
|
Int J Cancer
|
2011
|
1.00
|
|
51
|
C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).
|
Cancer Causes Control
|
2009
|
0.99
|
|
52
|
Reliability of follicle-stimulating hormone measurements in serum.
|
Reprod Biol Endocrinol
|
2003
|
0.98
|
|
53
|
DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
|
Cancer Epidemiol
|
2010
|
0.98
|
|
54
|
Defining the genomic signature of the parous breast.
|
BMC Med Genomics
|
2012
|
0.97
|
|
55
|
Neutral endopeptidase protein expression and prognosis in localized prostate cancer.
|
Clin Cancer Res
|
2004
|
0.97
|
|
56
|
Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.
|
Clin Cancer Res
|
2004
|
0.97
|
|
57
|
Temporal reliability of cytokines and growth factors in EDTA plasma.
|
BMC Res Notes
|
2010
|
0.95
|
|
58
|
Insulin-like growth factor II and colorectal cancer risk in women.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.95
|
|
59
|
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
|
Breast Cancer Res
|
2013
|
0.95
|
|
60
|
Reproducibility of serum pituitary hormones in women.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.95
|
|
61
|
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.
|
Br J Haematol
|
2014
|
0.95
|
|
62
|
Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.95
|
|
63
|
Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement.
|
J Magn Reson Imaging
|
2013
|
0.94
|
|
64
|
Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
|
J Clin Oncol
|
2003
|
0.94
|
|
65
|
Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.
|
Acta Oncol
|
2007
|
0.93
|
|
66
|
IGF-I during primiparous pregnancy and maternal risk of breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.92
|
|
67
|
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
|
Am J Epidemiol
|
2008
|
0.92
|
|
68
|
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
|
Cancer Epidemiol
|
2012
|
0.92
|
|
69
|
Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma.
|
Clin Cancer Res
|
2003
|
0.91
|
|
70
|
Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).
|
Cancer Causes Control
|
2014
|
0.90
|
|
71
|
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.
|
Clin Cancer Res
|
2003
|
0.90
|
|
72
|
Chemoprevention strategies for prostate cancer.
|
Eur J Cancer Prev
|
2002
|
0.90
|
|
73
|
Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
|
Radiology
|
2013
|
0.90
|
|
74
|
Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.90
|
|
75
|
Characterization of a genomic signature of pregnancy identified in the breast.
|
Cancer Prev Res (Phila)
|
2011
|
0.89
|
|
76
|
Factors associated with inflammation markers, a cross-sectional analysis.
|
Cytokine
|
2011
|
0.89
|
|
77
|
Body mass index in relation to ovarian cancer: a multi-centre nested case-control study.
|
Int J Cancer
|
2002
|
0.89
|
|
78
|
Endogenous hormones and coronary heart disease in postmenopausal women.
|
Atherosclerosis
|
2011
|
0.89
|
|
79
|
Cox regression model with time-varying coefficients in nested case-control studies.
|
Biostatistics
|
2010
|
0.88
|
|
80
|
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
|
Eur J Cancer Prev
|
2005
|
0.87
|
|
81
|
Circulating vitamin d and risk of epithelial ovarian cancer.
|
J Oncol
|
2009
|
0.87
|
|
82
|
Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.
|
Cancer Res
|
2010
|
0.86
|
|
83
|
Association between adult height, genetic susceptibility and risk of glioma.
|
Int J Epidemiol
|
2012
|
0.86
|
|
84
|
Genetic variants in hormone-related genes and risk of breast cancer.
|
PLoS One
|
2013
|
0.85
|
|
85
|
Insulin-like growth factor I in pregnancy and maternal risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.84
|
|
86
|
Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.83
|
|
87
|
Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.
|
Int J Cancer
|
2012
|
0.83
|
|
88
|
Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.82
|
|
89
|
Maternal hormones during early pregnancy: a cross-sectional study.
|
Cancer Causes Control
|
2010
|
0.82
|
|
90
|
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
|
Int J Cancer
|
2014
|
0.82
|
|
91
|
Circulating prolactin levels and risk of epithelial ovarian cancer.
|
Cancer Causes Control
|
2013
|
0.81
|
|
92
|
Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity.
|
Biostatistics
|
2013
|
0.81
|
|
93
|
Quantifying the dose-response relationship between circulating folate concentrations and colorectal cancer in cohort studies: a meta-analysis based on a flexible meta-regression model.
|
Am J Epidemiol
|
2013
|
0.80
|
|
94
|
Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.
|
Magn Reson Imaging
|
2012
|
0.80
|
|
95
|
Re: C-reactive protein and risk of breast cancer.
|
J Natl Cancer Inst
|
2008
|
0.80
|
|
96
|
Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
|
Blood Cells Mol Dis
|
2008
|
0.79
|
|
97
|
Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women.
|
Br J Nutr
|
2010
|
0.79
|
|
98
|
Serum taurine and risk of coronary heart disease: a prospective, nested case-control study.
|
Eur J Nutr
|
2012
|
0.78
|
|
99
|
Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.
|
Future Oncol
|
2014
|
0.78
|
|
100
|
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4.
|
Cancer Causes Control
|
2013
|
0.78
|
|
101
|
Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
|
Cancer Causes Control
|
2003
|
0.78
|
|
102
|
Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies.
|
Cancer Causes Control
|
2015
|
0.76
|
|
103
|
Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.76
|
|
104
|
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.
|
Anticancer Res
|
2011
|
0.76
|
|
105
|
Circulating soluble Fas levels and risk of ovarian cancer.
|
BMC Cancer
|
2003
|
0.75
|
|
106
|
Correction: vitamin d metabolic pathway genes and pancreatic cancer risk.
|
PLoS One
|
2015
|
0.75
|
|
107
|
Soy protein and recurrence of prostate cancer--reply.
|
JAMA
|
2013
|
0.75
|
|
108
|
Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.
|
Cancer Causes Control
|
2011
|
0.75
|